Table 3.

Characteristics of hepatitis B serosurvey participants in the Cook Islands, Kiribati, Niue, and Tokelau.

	Cook Islands, 2012			Kiribati, 2014			Niue, 2015			Tokelau, 2014
	n	N	%	n	N	Weighted%	n	N	%	n	N	%
Participation	269	314	86	1249	1293	96 (94–99)	183	216	85	171	171	100
Grade^a
Early Childhood Education (ECE)							22	30	73
1				1249	1249	100	24	30	80	22	22	100
2	269	269	100				29	34	85	27	27	100
3							28	32	88	30	30	100
4							30	30	100	23	23	100
5							22	29	76	39	39	100
6							28	31	90	29	29	100
Male	149	269	55	664	1288	51 (48–54)				98	171	57
Born in country	241	265	91	1285	1293	99 (99–100)				59	171	35
Ethnicity
Maori/Polynesian	252	257	98							163	171	95
Caucasian	5	257	2
Melanesian	0	257	0							1	171	1
Mixed										7	171	4
Vaccination data available for review	258	269	96	104	1293	9 (3–16)	17	183	9	171	171	100
Any Birth Dose (HepB-BD)^b	249	258	97							162	171	95
Received HepB-BD ⩽24 h	245	258	95							73	95	77
Received 3+ doses of hepatitis B	258	258	100							171	171	100
HBsAg+	0	269	0	39	1249	3.3 (2.4–4.6)	0	183	0	0	171	0

Tokelau: 1 child home schooled but included in survey.

Any birth dose is defined as a dose within 41 days of life (Cook Islands) or marked on vaccination card as ‘birth dose’ but no date provided (Tokelau).